Both the complement fixation test (CFT) and the hemagglutination test are immunological tests used to find out whether a biological sample contains particular antibodies or antigens. These assays are frequently used in research, clinical diagnosis, and immunology.Â
A serological technique called the complement fixation test detects the presence of particular antibodies in a patient’s serum sample. This test is based on how antibodies and complement proteins interact to protect the immune system from external invaders like bacteria and viruses.
The CFT operates as follows:
- The test includes mixing various dilutions of the patient’s serum with a predetermined quantity of an antigen (such as a virus or bacterial component) in a succession of tubes or wells.
- Specific antibodies against the antigen will attach to the antigen molecules if the patient’s serum contains those antibodies. The complement cascade can then be activated as a result of complement proteins binding to the antigen-antibody complexes.
- Hemoglobin is released when indicator cells—typically sheep or rabbit red blood cells—are lysed (destroyed) in the complement cascade’s last stage. The color or turbidity will change, making this lysis visible.
- The complement proteins will “fix” to the antigen-antibody complexes if antibodies are present in the blood sample. As a result, the indicator cells won’t be damaged and the complement cascade won’t be triggered.
Hemagglutination and complement fixation tests are crucial immunological methods for identifying particular immune responses and comprehending the interactions between antigens and antibodies.
Hemagglutination test results:
- Red blood cells are combined with antigens (such as bacterial or viral particles). They will attach to both the antigen and the red blood cells if particular antibodies directed against these antigens are found in the test sample. Red blood cells agglutinate as a result, generating distinct clumps.
- Depending on the quantity of antibodies and the potency of the antigen-antibody interaction, the degree of agglutination can change. The test can be used statistically to calculate the titer of the antibodies or qualitatively to assess whether or not a particular antibody is present.
Hemagglutination and complement fixation tests are crucial immunological methods for identifying particular immune responses and comprehending the interactions between antigens and antibodies.
S.No. |
Aspect |
Complement Fixation Test |
Hemagglutination Test |
1 |
Type of Test |
Serological |
Serological |
2 |
Purpose |
Detect antibodies or antigens |
Detect antibodies or antigens |
3 |
Principle |
Measures the consumption of complement |
Agglutination of red blood cells |
4 |
Components Required |
Serum, complement, antigen, and antibodies |
Antigen-coated red blood cells |
5 |
Sensitivity |
High sensitivity |
Variable sensitivity |
6 |
Specificity |
High specificity |
Variable specificity |
7 |
Sensitivity to Antibodies |
Detects both IgG and IgM antibodies |
Mainly detects IgM antibodies |
8 |
Antigen Detection |
Detects soluble antigens |
Detects particulate antigens |
9 |
Incubation Time |
Requires longer incubation time |
Typically shorter incubation time |
10 |
Result Measurement |
Based on complement fixation |
Based on agglutination |
11 |
Quantitative Measurement |
Can be quantitatively measured |
Usually qualitative, titration possible |
12 |
Common Uses |
Diagnose viral and bacterial infections |
Blood typing, serological diagnosis |
13 |
Cross-Reactions |
Less prone to cross-reactions |
More prone to cross-reactions |
14 |
Equipment |
Requires specialized equipment |
Basic laboratory equipment |
15 |
Risk of Hemolysis |
Lower risk of hemolysis |
Higher risk of hemolysis |
16 |
Handling of Blood Samples |
Serum or plasma needed |
Whole blood or serum samples used |
17 |
Result Interpretation |
Positive if no complement fixation |
Positive if agglutination observed |
18 |
Test Complexity |
More complex to perform |
Simpler and quicker to perform |
19 |
Cost |
Generally more expensive |
Generally less expensive |
20 |
Sensitivity to Antigen Size |
Suitable for small antigens |
Suitable for larger antigens |
21 |
Viral Infections |
Useful for diagnosing some viral infections |
Less commonly used for viral infections |
22 |
Bacterial Infections |
Useful for diagnosing some bacterial infections |
Less commonly used for bacterial infections |
23 |
Validation |
Requires a control sample for validation |
Control sample less critical |
24 |
Examples |
Used in syphilis, brucellosis diagnosis |
Used in blood typing, influenza diagnosis |
25 |
Hemagglutination Type |
Not associated with hemagglutination |
Relies on hemagglutination reaction |
26 |
Hemagglutination Inhibition |
Does not involve hemagglutination |
Utilizes hemagglutination inhibition |
27 |
Interpretation of Results |
Based on the absence/presence of fixation |
Based on the presence/absence of agglutination |
28 |
Antigen Sources |
Various antigen sources can be used |
Usually, specific RBC antigens are used |
29 |
Diagnostic Sensitivity |
May have higher diagnostic sensitivity |
May have lower diagnostic sensitivity |
30 |
Risk of False Positives |
Lower risk of false positives |
Higher risk of false positives |
31 |
Risk of False Negatives |
Lower risk of false negatives |
Higher risk of false negatives |
32 |
Test Duration |
Longer test duration |
Shorter test duration |
33 |
Automation |
Less amenable to automation |
More amenable to automation |
34 |
Interpretation of Titers |
Titers are not typically used |
Titers may be used for quantitative analysis |
35 |
Serum Handling |
Serum must be heat-inactivated |
Serum may not require heat-inactivation |
36 |
Research vs. Clinical Use |
More commonly used in research settings |
More commonly used in clinical settings |
37 |
Availability |
May not be widely available in all labs |
Generally available in most labs |
38 |
Historical Significance |
Developed earlier in the history of serology |
Developed later in the history of serology |
Frequently Asked Questions (FAQs)
Q.1 What does the CFT intend to achieve?
Certain infectious disorders, particularly those brought on by viruses and bacteria that are challenging to grow, are diagnosed using the CFT. A person’s immunological response to vaccinations or earlier diseases is also ascertained using this method.
Q.2 What are the CFT's restrictions?
It is difficult and time-consuming to perform the CFT since live complement proteins are involved. Additionally, it is expensive and calls for knowledgeable staff and specialized equipment.
Q.3 How is the outcome of the hemagglutination test interpreted?
Positive outcomes demonstrate observable agglutination, which denotes the presence of particular antibodies or viruses. The titer, or the dilution at which agglutination takes place, can reveal details about the immunological response of the patient.
Q.4 Why is the hemagglutination test performed?
The Hemagglutination Test is mainly used to identify viral infections like influenza and certain viruses that cause respiratory or gastrointestinal diseases.
Q.5 What is the process of the hemagglutination test?
Red blood cells are combined with the patient’s serum for this test. These antibodies will bind to the virus if the serum has particular antibodies against the virus. As a result, the red blood cells that have been exposed to the virus clump together.